Loading organizations...
Kipling Capital is a real estate investment firm that raises equity capital for a diverse range of real estate projects. The firm specializes in securing funding for various property types, including office, industrial, retail, resort, and residential assets, serving as a capital source for investment managers and wealth builder for high-net-worth individuals, families, and trusts. Since its inception, Kipling Capital's principals have successfully raised $2.2 billion in equity capital, deployed across over 1,000 real estate projects with an aggregate value exceeding $8.0 billion. These investments typically target annual investor returns (IRR) ranging from 9.5% to 58%. Kipling Capital was established in 1998. Its business model centers on they raise equity capital from high-net-worth investors and deploy it into real estate projects, generating returns through property appreciation and cash flow.
KIP Capital has 1 tracked investment across 1 company. The latest tracked deal is $72.1M Series B in Ascentage Pharma in January 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 9, 2017 | Ascentage Pharma | $72.1M Series B | Future Industry Ventures | Efung Capital, Hidragon Capital, Oriza Ventures, Shiyu Capital, YuanMing Capital |